共 254 条
[1]
Afshar-Oromieh A(2013)PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions Eur J Nucl Med Mol Imaging 40 486-495
[2]
Malcher A(2014)Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer Eur J Nucl Med Mol Imaging 41 11-20
[3]
Eder M(2015)The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer Eur J Nucl Med Mol Imaging 42 197-209
[4]
Eisenhut M(2021)Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis Eur J Nucl Med Mol Imaging 48 2978-2989
[5]
Linhart HG(2020)The automated bone scan index as a predictor of response to prostate radiotherapy in men with newly diagnosed metastatic prostate cancer: an exploratory analysis of STAMPEDE's "M1|RT comparison" Eur Urol Oncol 3 412-419
[6]
Hadaschik BA(2018)Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer: a secondary analysis of a randomized clinical trial JAMA Oncol 4 944-951
[7]
Afshar-Oromieh A(2016)Evaluation of prostate cancer bone metastases with 18F-NaF and 18F-fluorocholine PET/CT J Nucl Med 57 55S-60S
[8]
Zechmann CM(2012)18F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy Eur J Nucl Med Mol Imaging 39 1730-1736
[9]
Malcher A(2016)The bone microenvironment: a fertile soil for tumor growth Curr Osteoporos Rep 14 151-158
[10]
Eder M(2019)18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial Lancet Oncol 20 1286-1294